Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-047538

President and COO sold 3,000 shares at an average $8.66 ($25,968)

  • President and COO acquired 3,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Larson Tina Marriott · President and COO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-24 Exercise or conversion : show line 1 in the form 10b5-1 +3,000 $1.06 $3,180 421,782 D
2023-08-24 Sale : show line 2 in the form 10b5-1 −2,937 $8.64 $25,373 418,845 D
2023-08-24 Sale : show line 3 in the form 10b5-1 −63 $9.45 $596 418,782 D
Open-market sales · 3,000 sh · avg $8.66 · $25,968

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-08-24 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −3,000 $1.06 2028-07-22 3,000 529,000 D
Loading xslF345X05/doc4.xml…